Strimvelis
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Strimvelis, covering 2025-12-18 to 2025-12-18. Get the full timeline:
Most recent: EMA Authorised: Strimvelis (autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human adenosine deaminase (ADA) cDNA sequence from human haematopoietic stem/progenitor (CD34+) cells) — Fondazione Telethon ETS